Grifols SA (GRF) – Company Profile and SWOT Analysis
- Pages: 68
- Published: June 2024
- Report Code: MLPH7524FSA
Grifols SA (GRF) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Grifols SA (Grifols) develops, produces, and markets plasma-derived medicines and transfusion medicines. The company is focused on research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. It produces plasma derived protein therapies for patients suffering with rare, chronic and life-threatening infections. The company's major products include essential plasma-derived medicines for treating conditions across various therapeutic areas such as neurology, immunology, hepatology, intensive care, pulmonology, hematology, and infectious diseases. Grifols provides transfusion medicine, hemostasis and immunoassay solutions for blood banks, clinical laboratories and transfusion centers. The company offers its products to hospitals, pharmacies and healthcare professionals. It offers products in the US, Canada, Europe, and Rest of the world. Grifols is headquartered in Barcelona, Spain.
Scope
• Detailed information on Grifols SA required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Grifols SA in the form of a SWOT analysis
• An in-depth view of the business model of Grifols SA including a breakdown and examination of key business segments
• News about Grifols SA, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Grifols SA and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Grifols SA as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Grifols SAs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Vertex Pharmaceuticals Inc
Oryzon Genomics SA
Korro Bio Inc
Kamada Pharmaceuticals
Abeona Therapeutics Inc
AATec Medical GmbH
Mereo Biopharma Group Plc
AB-Biotics SA
Takeda Pharmaceutical Co Ltd
Kedrion Biopharma Inc
Bio Products Laboratory Ltd
Sanofi
Octapharma Plasma Inc
HemaCare Corp
Omnicell Inc
CSL Behring GmbH
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.